NO20090819L - (S)-(-)-amlopidinkamsylat eller hydrat derav og farmasoytisk preparat omfattende dette - Google Patents

(S)-(-)-amlopidinkamsylat eller hydrat derav og farmasoytisk preparat omfattende dette

Info

Publication number
NO20090819L
NO20090819L NO20090819A NO20090819A NO20090819L NO 20090819 L NO20090819 L NO 20090819L NO 20090819 A NO20090819 A NO 20090819A NO 20090819 A NO20090819 A NO 20090819A NO 20090819 L NO20090819 L NO 20090819L
Authority
NO
Norway
Prior art keywords
hydrate
pharmaceutical composition
camylate
amlopidine
pinamyl
Prior art date
Application number
NO20090819A
Other languages
English (en)
Norwegian (no)
Inventor
Jaeheon Lee
Moon Sub Lee
Weon Ki Yang
Jeaho Yoo
Jae-Chul Lee
Chang-Ju Choi
Han Kyong Kim
Young-Kill Chang
Gwansun Lee
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of NO20090819L publication Critical patent/NO20090819L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
NO20090819A 2006-07-21 2009-02-20 (S)-(-)-amlopidinkamsylat eller hydrat derav og farmasoytisk preparat omfattende dette NO20090819L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020060068401A KR100913791B1 (ko) 2006-07-21 2006-07-21 (ｓ)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물
PCT/KR2007/003444 WO2008010659A1 (en) 2006-07-21 2007-07-16 (s)-(-)-amlodipine camsylate or hydrate thereof and pharmaceutical composition comprising same

Publications (1)

Publication Number Publication Date
NO20090819L true NO20090819L (no) 2009-02-20

Family

ID=38956963

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090819A NO20090819L (no) 2006-07-21 2009-02-20 (S)-(-)-amlopidinkamsylat eller hydrat derav og farmasoytisk preparat omfattende dette

Country Status (19)

Country Link
US (1) US20090326234A1 (ko)
EP (1) EP2044022A1 (ko)
JP (1) JP2009544695A (ko)
KR (1) KR100913791B1 (ko)
CN (1) CN101495451B (ko)
AR (1) AR062009A1 (ko)
AU (1) AU2007276038B2 (ko)
BR (1) BRPI0714313A2 (ko)
CA (1) CA2658384C (ko)
EC (1) ECSP089024A (ko)
IL (1) IL196318A0 (ko)
MX (1) MX2009000454A (ko)
MY (1) MY152884A (ko)
NO (1) NO20090819L (ko)
NZ (1) NZ574006A (ko)
RU (1) RU2403241C1 (ko)
UA (1) UA93724C2 (ko)
WO (1) WO2008010659A1 (ko)
ZA (1) ZA200900231B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0924136B8 (pt) 2009-01-23 2021-05-25 Hanmi Holdings Co Ltd composição farmacêutica sólida compreendendo amlodipina e losartan e método para a preparação da mesma
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
WO2020054296A1 (ja) * 2018-09-12 2020-03-19 富士フイルム株式会社 薬液、基板の処理方法
CN113041244B (zh) 2019-11-08 2022-06-21 施慧达药业集团(吉林)有限公司 含苯磺酸左氨氯地平水合物的组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
KR100452491B1 (ko) * 2001-03-29 2004-10-12 한미약품 주식회사 신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
WO2002079518A1 (en) 2001-03-29 2002-10-10 Chugai Seiyaku Kabushiki Kaisha A method for genotyping individuals for multiple snps
CN1152013C (zh) * 2001-11-22 2004-06-02 张喜田 一类左旋氨氯地平盐的水合物及其制剂
KR20040011751A (ko) * 2002-07-30 2004-02-11 씨제이 주식회사 암로디핀의 유기산염
WO2004067512A1 (en) * 2003-01-27 2004-08-12 Hanmi Pharm. Co., Ltd. Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof
KR100841409B1 (ko) * 2003-12-16 2008-06-25 에스케이케미칼주식회사 암로디핀 겐티세이트 염과 이의 제조방법
US7858801B2 (en) * 2004-10-20 2010-12-28 Emcure Pharmaceuticals Limited Process for producing enantiomer of amlodipine in high optical purity
GB0502509D0 (en) * 2005-02-07 2005-03-16 Pfizer Ltd Novel salt form of a dopamine agonist

Also Published As

Publication number Publication date
IL196318A0 (en) 2009-09-22
KR100913791B1 (ko) 2009-08-26
AR062009A1 (es) 2008-08-10
NZ574006A (en) 2010-09-30
MY152884A (en) 2014-11-28
MX2009000454A (es) 2009-01-28
US20090326234A1 (en) 2009-12-31
RU2009106073A (ru) 2010-08-27
AU2007276038A1 (en) 2008-01-24
KR20080008752A (ko) 2008-01-24
AU2007276038B2 (en) 2011-06-16
UA93724C2 (ru) 2011-03-10
JP2009544695A (ja) 2009-12-17
EP2044022A1 (en) 2009-04-08
ECSP089024A (es) 2009-01-30
CN101495451A (zh) 2009-07-29
CA2658384A1 (en) 2008-01-24
ZA200900231B (en) 2010-04-28
WO2008010659A1 (en) 2008-01-24
BRPI0714313A2 (pt) 2013-04-02
CA2658384C (en) 2012-01-17
RU2403241C1 (ru) 2010-11-10
CN101495451B (zh) 2012-07-25

Similar Documents

Publication Publication Date Title
WO2009117421A3 (en) Heterocyclic modulators of gpr119 for treatment of disease
NO20091700L (no) Florizinanaloger som inhibitorer av glukose-ko-transporter 2
WO2008033562A3 (en) Kinase inhibitor compounds
WO2008042231A3 (en) Compositions and methods for evaluating and treating heart failure
WO2008036765A3 (en) Micrornas differentially expressed in pancreatic diseases and uses thereof
NO20084747L (no) Tetrahydropteridiner anvendbare som inhibitorer av protein kinaser
WO2008067219A3 (en) Quinazolinone modulators of tgr5
WO2010077898A3 (en) Trans-chloro-3,3,3-trifluoropropene for use in chiller applications
WO2008008887A3 (en) Gpr119 agonists for treating metabolic disorders
WO2008112022A8 (en) 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
WO2009027346A3 (de) 17beta-hydroxysteroid-dehydrogenase-typ1-inhibitoren zur behandlung hormonabhängiger erkrankungen
WO2009153496A3 (fr) Composes agonistes ppar, preparation et utilisations pour le traitement du diabete et/ou des dyslipidemies
BRPI0716210A2 (pt) Métodos, composições e aparelhos para tratar feridas com pressões diferentes da atmosférica
WO2007109024A3 (en) Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
EA200900091A1 (ru) Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний
WO2009155001A3 (en) Wnt protein signalling inhibitors
WO2007087575A3 (en) Compositions and methods for treating pulmonary hypertension
WO2009026334A3 (en) Treatment with kallikrein inhibitors
WO2007125105A3 (en) Benzamide glucokinase activators
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
AU2007243282A8 (en) Compositions and methods for the treatment of cardiovascular disease
DK2467364T3 (da) Nitrogen-holdige forbindelser og farmaceutiske sammensætninger for behandling af atrial flimren.
WO2010077339A3 (en) β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF
BRPI0906608A2 (pt) Métodos e composições para o tratamento de hemorragia subaracnóide aneurismal coronária e arterial.
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application